Fred Craves
Fondateur chez MADRIGAL PHARMACEUTICALS, INC.
Fortune : 95 M $ au 31/05/2024
Profil
Fred Bernard Craves is the founder of Burrill & Craves (founded in 1994), Bay City Capital LLC (founded in 1997), and Madrigal Pharmaceuticals, Inc. (founded in 2011).
He holds the title of Managing Director at Bay City Capital LLC and Chairman at Madrigal Pharmaceuticals, Inc. He is also the founder of Creative Biomolecules, Inc. Dr. Craves's current job(s) include Chairman & Chief Executive Officer at Imidomics, Inc., Chairman at Epoch Biosciences, Inc., Director at Incyte Genomics Inc., Director at EOS Biotechnology, Inc., Director at Synchronicity Pharma, Inc., Director at Tallikut Pharmaceuticals, Inc., Director at Encarta, Inc., Director at Bay City Capital GF Xinde Intl Life Sciences USD Fund LP, Director at KBP Biosciences USA, Inc., Trustee at Loyola Marymount University, and Advisor at IIF Management Co. LLC.
His former job(s) include Chairman & Chief Executive Officer at Codon Devices, Inc., President & Chief Executive Officer at Berlex Biosciences, Chairman & Chief Executive Officer at Codon Corp., President & Chief Executive Officer at Berlex Laboratories, Inc., Chairman at Reliant Pharmaceuticals LLC, Independent Director at Poniard Pharmaceuticals, Inc., Director at Medarex, Inc., Director at Synta Pharmaceuticals Corp., Director at Ion Torrent Systems, Inc., Independent Director at Twist Bioscience Corp., Director at Galileo Pharmaceuticals, Inc., Director at Incyte Pharmaceuticals, Inc., Director at BioSeek, Inc., Director at VIA Pharmaceuticals, Inc., Director at GENTURAdx USA, Inc., Lead Independent Director at Dermira, Inc., and Executive Vice President at Schering Berlin, Inc. Dr. Craves's education history includes a graduate degree from Wayne State University (Michigan), a doctorate degree from The University of California, San Francisco, and an undergraduate degree from Georgetown University.
Dr. Craves is also the founder of Creative Biomolecules, Inc...
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2024 | 403 572 ( 1,89% ) | 95 M $ | 31/05/2024 |
Postes actifs de Fred Craves
| Sociétés | Poste | Début |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Fondateur | 01/09/2011 |
Epoch Biosciences, Inc.
 Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Président | - |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Directeur/Membre du Conseil | - |
Bay City Capital GF Xinde Intl Life Sciences USD Fund LP
 Bay City Capital GF Xinde Intl Life Sciences USD Fund LP Investment ManagersFinance Bay City Capital GF Xinde International Life Sciences USD Fund LP invests in companies located United States, Canada, Western Europe and China. The Fund targets companies operating in the fields of life sciences. It provides financing for seed, early and later stage capital requirements. | Directeur/Membre du Conseil | - |
Imidomics, Inc.
 Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Directeur Général | - |
IIF Management Co. LLC
 IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Consultant / Advisor | - |
| Encarta, Inc. | Directeur/Membre du Conseil | - |
| Tallikut Pharmaceuticals, Inc. | Directeur/Membre du Conseil | - |
| Loyola Marymount University | Directeur/Membre du Conseil | - |
| ░░░ ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Fred Craves
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Fred Craves
| Wayne State University (Michigan) | Graduate Degree |
| The University of California, San Francisco | Doctorate Degree |
| Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| VIA PHARMACEUTICALS, INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 28 |
|---|---|
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Epoch Biosciences, Inc.
Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Health Technology |
Schering Berlin, Inc.
 Schering Berlin, Inc. Medical SpecialtiesHealth Technology Part of Bayer AG, Schering Berlin, Inc. is a company that manufactures pharmaceuticals and diagnostic substances. The company is based in Whippany, NJ. | Health Technology |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Codon Devices, Inc.
 Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Ion Torrent Systems, Inc.
 Ion Torrent Systems, Inc. SemiconductorsElectronic Technology Ion Torrent Systems, Inc. develops semiconductor chips for DNA sequencing systems. The company was founded in 2007 and is headquartered in Guilford, CT. | Electronic Technology |
Galileo Pharmaceuticals, Inc.
 Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |
| Incyte Genomics Inc. /Micoarray Operations/ | Commercial Services |
Incyte Pharmaceuticals, Inc.
 Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Health Technology |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Health Technology |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
BioSeek, Inc.
 BioSeek, Inc. Miscellaneous Commercial ServicesCommercial Services BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development. Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand. Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety. | Commercial Services |
| Berlex Biosciences | |
| Burrill & Craves | |
| Codon Corp. | |
GENTURAdx USA, Inc.
 GENTURAdx USA, Inc. Medical SpecialtiesHealth Technology GENTURAdx USA, Inc. manufactured biotechnology instruments. The firm provided tools necessary for detection and treatment of diseases and drug discoveries. It had offices in the Silicon Valley, Hong Kong, Shanghai and Suzhou. The company was founded by Steve Yu and Jesus Ching in June 2005 and was headquartered in Hayward, CA. | Health Technology |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
Madrigal Pharmaceuticals, Inc. /Old/
 Madrigal Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Madrigal Pharmaceuticals, Inc. develops small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. It specializes in the treatment of both niche and prevalent indications, including fatty liver disease and non-alcoholic steatohepatitis, diabetes, dyslipidemia, and cardiovascular disease. The company was founded by Rebecca A. Taub, Brian N. Cunningham, and Edward Chiang in September 2011 and is headquartered in Fort Washington, PA. | Health Technology |
| Berlex Laboratories, Inc. | |
| Tallikut Pharmaceuticals, Inc. | |
| Encarta, Inc. | |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Finance |
Bay City Capital GF Xinde Intl Life Sciences USD Fund LP
Bay City Capital GF Xinde Intl Life Sciences USD Fund LP Investment ManagersFinance Bay City Capital GF Xinde International Life Sciences USD Fund LP invests in companies located United States, Canada, Western Europe and China. The Fund targets companies operating in the fields of life sciences. It provides financing for seed, early and later stage capital requirements. | Finance |
KBP Biosciences USA, Inc.
 KBP Biosciences USA, Inc. Miscellaneous Commercial ServicesCommercial Services KBP Biosciences engages in conducting biotechnological research to develop therapies for patients. The company was founded by Huang Zhenhua in and is headquartered in Princeton, NJ. | Commercial Services |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Health Technology |
